Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   Chemical Modulation of Pre-mRNA Splicing in Mammalian Systems
  2. Boer, Robert E.; Torrey, Zachary R.; Schneekloth,Jay
  3. ACS CHEMICAL BIOLOGY. 2020, Apr 17; 15(4): 808-818.
  1. 2.   Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
  2. Ou, Li; Kong, Wing-Pui; Chuang, Gwo-Yu; Ghosh, Mridul; Gulla, Krishana; O'Dell, Sijy; Varriale, Joseph; Barefoot, Nathan; Changela, Anita; Chao, Cara W; Cheng, Cheng; Druz, Aliaksandr; Kong, Rui; McKee, Krisha; Rawi, Reda; Sarfo, Edward K; Schön, Arne; Shaddeau, Andrew; Tsybovsky,Yaroslav; Verardi, Raffaello; Wang, Shuishu; Wanninger, Timothy G; Xu, Kai; Yang, Gengcheng J; Zhang, Baoshan; Zhang, Yaqiu; Zhou, Tongqing; Arnold, Frank J; Doria-Rose, Nicole A; Lei, Q Paula; Ryan, Edward T; Vann, Willie F; Mascola, John R; Kwong, Peter D
  3. Scientific reports. 2020, Feb 20; 10(1): 3032.
  1. 3.   Cullin neddylation may allosterically tune polyubiquitin chain length and topology
  2. Onel, Melis; Sumbul, Fidan; Liu, Jin; Nussinov, Ruth; Haliloglu, Turkan
  3. BIOCHEMICAL JOURNAL. 2017, Feb 20; 474(5): 781-795.
  1. 4.   Control of transcriptional pausing by biased thermal fluctuations on repetitive genomic sequences
  2. Imashimizu, M.; Afek, A.; Takahashi, H.; Lubkowska, Lucyna; Lukatsky, D. B.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2016, Nov 22; 113(47): E7409-E7417.
  1. 5.   Identification of a Src Tyrosine Kinase/SIAH2 E3 Ubiquitin Ligase Pathway That Regulates C/EBP delta Expression and Contributes to Transformation of Breast Tumor Cells
  2. Sarkar, T. R.; Sharan, S.; Wang, J.; Pawar, S. A.; Cantwell, C. A.; Johnson, P. F.; Morrison, D. K.; Wang, J. M.; Sterneck, E.
  3. Molecular and Cellular Biology. 2012, Jan; 32(2): 320-332.
  1. 6.   C/EBP-delta regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1 alpha
  2. Min, Y.; Ghose, S.; Boelte, K.; Li, J.; Yang, L.; Lin, P. C.
  3. Oncogene. 2011, Dec; 30(49): 4901-4909.
  1. 7.   CEBPD Reverses RB/E2F1-Mediated Gene Repression and Participates in HMDB-Induced Apoptosis of Cancer Cells
  2. Pan, Y. C.; Li, C. F.; Ko, C. Y.; Pan, M. H.; Chen, P. J.; Tseng, J. T.; Wu, W. C.; Chang, W. C.; Huang, A. M.; Sterneck, E.; Wang, J. M.
  3. Clinical Cancer Research. 2010, Dec; 16(23): 5770-5780.
  1. 8.   The tumour suppressor C/EBP delta inhibits FBXW7 expression and promotes mammary tumour metastasis
  2. Balamurugan, K.; Wang, J. M.; Tsai, H. H.; Sharan, S.; Anver, M.; Leighty, R.; Sterneck, E.
  3. Embo Journal. 2010, Dec; 29(24): 4106-4117.
  1. 9.   C/EBP ? targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression
  2. Pawar, S. A.; Sarkar, T. R.; Balamurugan, K.; Sharan, S.; Wang, J.; Zhang, Y. H.; Dowdy, S. F.; Huang, A. M.; Sterneck, E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, May 18; 107(20): 9210-9215.
  1. 10.   Preferred drifting along the DNA major groove and cooperative anchoring of the p53 core domain: mechanisms and scenarios
  2. Pan, Y. P.; Nussinov, R.
  3. Journal of Molecular Recognition. 2010, Mar-Apr; 23(2): 232-240.
  1. 11.   C/EBP beta regulates body composition, energy balance-related hormones and tumor growth
  2. Staiger, J.; Lueben, M. J.; Berrigan, D.; Malik, R.; Perkins, S. N.; Hursting, S. D.; Johnson, P. F.
  3. Carcinogenesis. 2009 30(5): 832-840.
  1. 12.   Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: Implications for antifungal therapy
  2. Hope, W. W.; Kruhlak, M. J.; Lyman, C. A.; Petraitiene, R.; Petraitis, V.; Francesconi, A.; Kasai, M.; Mickiene, D.; Sein, T.; Peter, J.; Kelaher, A. M.; Hughes, J. E.; Cotton, M. P.; Cotten, C. J.; Bacher, J.; Tripathi, S.; Bermudez, L.; Maugel, T. K.; Zerfas, P. M.; Wingard, J. R.; Drusano, G. L.; Walsh, T. J.
  3. Journal of Infectious Diseases. 2007, Feb; 195(3): 455-466.
  1. 13.   Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro
  2. Stone, G. W.; Barzee, S.; Snarsky, V.; Spina, C. A.; Lifson, J. D.; Pillai, V. K. B.; Amara, R. R.; Villinger, F.; Kornbluth, R. S.
  3. Clinical and Vaccine Immunology. 2006, Nov; 13(11): 1223-1230.
  1. 14.   c/ebp delta null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney
  2. Thangaraju, M.; Ananth, S.; Martin, P. M.; Roon, P.; Smith, S. B.; Sterneck, E.; Prasad, P. D.; Ganapathy, V.
  3. Journal of Biological Chemistry. 2006, Sep; 281(37): 26769-26773.
  1. 15.   The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain,, RING finger, and an E2-binding site
  2. Chen, B.; Mariano, J.; Tsai, Y. C.; Chan, A. H.; Cohen, M.; Weissman, A. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 10; 103(2): 341-346.
  1. 16.   Suppression of p65 phosphorylation coincides with inhibition of I kappa B alpha polyubiquitination and degradation
  2. Hu, J.; Haseebuddin, M.; Young, M.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, DEC; 44(4): 274-284.
  1. 17.   A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
  2. Burger, A. M.; Gao, Y. G.; Amemiya, Y.; Kahn, H. J.; Kitching, R.; Yang, Y. L.; Sun, P.; Narod, S. A.; Hanna, W. M.; Seth, A. K.
  3. Cancer Research. 2005, NOV 15; 65(22): 10401-10412.
  1. 18.   C/EBP delta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution
  2. Thangaraju, M.; Rudelius, M.; Bierie, B.; Raffeld, M.; Sharan, S.; Hennighausen, L.; Huang, A. M.; Sterneck, E.
  3. Development. 2005, NOV; 132(21): 4675-4685.
  1. 19.   The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappa B activity in drug-sensitive MCF-7 cells
  2. Brantley, E.; Patel, V.; Stinson, S. F.; Trapani, V.; Hose, C. D.; Ciolino, H. P.; Yeh, G. C.; Gutkind, J. S.; Sausville, E. A.; Loaiza-Perez, A. I.
  3. Anti-Cancer Drugs. 2005, FEB; 16(2): 137-143.
  1. 20.   Expression, purification, and properties of the Ubc4/5 family of E2 enzymes
  2. Lorick, K. L.; Jensen, J. P.; Weissman, A. M.
  3. Methods in Enzymology. 2005; 398 : 54-68.
  1. 21.   Expression and evaluation of RING finger proteins
  2. Yang, Y. L.; Lorick, K. L.; Jensen, J. P.; Weissman, A. M.
  3. Methods in Enzymology. 2005; 398 : 103-112.
  1. 22.   Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Alley, M. C.; Hose, C.; Ciolino, H. P.; Yeh, G. C.; Trepel, J. B.; Vistica, D. T.; Sausville, E. A.
  3. Molecular Cancer Therapeutics. 2004 3(6): 715-725.
  1. 23.   Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination
  2. Jeevan, A.; Yoshimura, T.; Lee, K. E.; McMurray, D. N.
  3. Infection and Immunity. 2003 71(1): 354-364.
  1. 24.   Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed attenuated and virulent mycobacteria
  2. Jeevan, A.; Yoshimura, T.; Foster, G.; McMurray, D. N.
  3. Infection and Immunity. 2002 70(3): 1245-1253.
  1. 25.   Mouse proteasomal ATPases Psmc3 and Psmc4: Genomic organization and gene targeting
  2. Sakao, Y.; Kawai, T.; Takeuchi, O.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Takeda, K.; Akira, S.
  3. Genomics. 2000 67(1): 1-7.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel